Recent Finacing
Recent Raise
Petra Pharma develops small-molecule inhibitors for enzyme pathways in cancer and metabolic diseases, operating from Accelerator-managed labs at Alexandria Center and collaborating with Weill Cornell Medicine on target discovery.
